Propiedad y actividad de insiders de Ascentage Pharma Group International (AAPG): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $15.40 |
| Capitalización | $1.4B |
| Bolsa | NASDAQ |
| País | CN |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-06-25 | Miyara Faical | |||
| 2026-05-21 | Zhai Yifan | M-Exempt | 95,575 | |
| 2026-05-21 | Zhai Yifan | M-Exempt | 92,746 | |
| 2026-05-20 | Zhai Yifan | A-Award | 298,195 | |
| 2026-05-20 | Zhai Yifan | A-Award | 298,194 | $2.0M |
| 2026-05-20 | Zhai Yifan | A-Award | 214,999 | |
| 2026-05-20 | Zhai Yifan | A-Award | 214,988 | $1.4M |
| 2026-05-20 | Zhai Yifan | A-Award | 103,365 | |
| 2026-05-20 | Zhai Yifan | A-Award | 103,364 | $839K |
| 2026-05-20 | Zhai Yifan | A-Award | 95,575 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $294.5M | $14.8M | $957.1M | $878.5M | $1.02B | $1.71B | $1.48B | $1.07B | $1.24B | $2.47B |
| Inversiones a Corto | $157.4M | $384.2M | $14.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $8.3M | $7.9M | $5.3M | $2.5M | $480000 | $54.1M | $61.5M | $163.5M | $99.1M | $253.1M |
| Inventario | 0 | 0 | 0 | 0 | 0 | $3.9M | $9.4M | $16.2M | $6.6M | $28.6M |
| Activos Corrientes | $463.7M | $414.7M | $990.2M | $909.1M | $1.08B | $1.89B | $1.64B | $1.34B | $1.47B | $2.95B |
| Inmovilizado Material | $4.5M | $25.3M | $34.0M | $110.2M | $477.0M | $854.3M | $650.0M | $957.2M | $905.9M | $829.6M |
| Fondo de Comercio | $24.7M | $24.7M | $24.7M | $24.7M | $24.7M | $24.7M | $24.7M | $24.7M | $24.7M | $24.7M |
| Activos Intangibles | $87.1M | $80.7M | $108.5M | $104.3M | $97.4M | $60.4M | $84.3M | $85.4M | $76.0M | $66.0M |
| Activos Totales | $593.3M | $581.7M | $1.23B | $1.21B | $1.73B | $2.94B | $2.83B | $2.50B | $2.62B | $3.97B |
| Cuentas por Pagar | $156000 | $3.8M | $5.1M | $13.1M | $23.4M | $70.9M | $95.6M | $72.4M | $92.0M | $106.8M |
| Deuda a Corto | 0 | 0 | $35.0M | $85.0M | $44.8M | $39.8M | $510.3M | $606.6M | $769.6M | $1.22B |
| Pasivos Corrientes | $77.6M | $79.5M | $105.3M | $202.1M | $276.1M | $361.1M | $881.2M | $934.2M | $1.17B | $1.64B |
| Deuda a Largo | 0 | 0 | 0 | 0 | $473.1M | $1.03B | $1.27B | $1.17B | $868.6M | $742.8M |
| Pasivos Totales | $607.9M | $713.5M | $2.24B | $314.6M | $884.4M | $1.71B | $2.42B | $2.43B | $2.34B | $2.63B |
| Reservas | -$152.0M | -$270.5M | -$615.8M | -$2.10B | -$2.77B | -$3.56B | -$4.44B | -$5.37B | -$5.77B | 0 |
| Patrimonio Neto | -$14.6M | -$131.8M | -$1.01B | $890.5M | $846.6M | $1.23B | $408.7M | $60.4M | $264.2M | $1.33B |
| Deuda Total | $830000 | $4.9M | $42.0M | $101.4M | $529.7M | $1.08B | $1.79B | $1.80B | $1.67B | $1.98B |
| Deuda Neta | -$451.1M | -$394.1M | -$929.4M | -$777.1M | -$490.3M | -$622.6M | $317.1M | $726.3M | $431.9M | -$490.7M |
| Capital Circulante | $386.1M | $335.2M | $885.0M | $707.0M | $802.9M | $1.52B | $755.3M | $410.0M | $307.6M | $1.30B |
Salud financiera
| Deuda / Patrimonio | 3.76 |
| Ratio corriente | 1.22 |
Rentabilidad
| Rentabilidad sobre capital | -153.85% |
| Rentabilidad sobre capital invertido | -48.88% |
| Rentabilidad sobre activos | -44.65% |
| Margen bruto | 81.56% |
| Margen operativo | -218.76% |
| Margen neto | -228.69% |
Empresas relacionadas: APGE · CELC · CGON · CNTA · IRON · LEGN · RARE
Explorar sector: Healthcare · Biotechnology
Más secciones de AAPG: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones